Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance.
暂无分享,去创建一个
N. Traficante | S. Fereday | A. deFazio | D. Bowtell | K. Lindemann | K. Alsop | P. Harnett | B. Gao | C. Emmanuel | C. Mapagu